LeonaBio
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18706 N Creek Pkwy Ste 104, Bothell, Was...Website
www.leonabio.comRevenue
<$5 MillionIndustry
About LeonaBio
LeonaBio Org Chart
Is LeonaBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when LeonaBio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if LeonaBio has recently received funding, and reach out quickly before it becomes old news!
Check out if LeonaBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on LeonaBio recently announced quarterly report
Click to see if LeonaBio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at LeonaBio
Funding: Get notified immidiatlly once LeonaBio has new funding data
LeonaBio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
LeonaBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LeonaBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LeonaBio.
Most Recent Scoops
LeonaBio News & Media
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
BOTHELL, Wash., May 27, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it will participate in the 5th Annual ALS Drug Development Summit, taking place June 2-4, 2026 in Boston, MA, and the BIO International Convention, taking place June 22-25, 2026 in San Diego, CA.LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
LeonaBio, Inc. (NASDAQ: LONA), announced the appointment of Fred Callori, J.D., Natalie Holles, and Peter Silverman, J.D. to its Board of Directors.LeonaBio, Inc. (LONA) Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene Transcript
LeonaBio, Inc. (LONA) Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, 2026...LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
Management to be Joined by Two Clinical Leaders in the Breast Cancer Field
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LeonaBio
LeonaBio, Inc. is a biotechnology company dedicated to the discovery and development of novel therapeutics, including small-molecule drug candidates for treatment-resistant metastatic breast cancer, amyotrophic lateral sclerosis (ALS), and other serious conditions. It was previously known as Athira Pharma, Inc. and recently rebranded to LeonaBio to... Read More